Kawasaki Medical University installs first MILabs E-Class U-SPECT6/CT in Japan

NewsGuard 100/100 Score

Kawasaki Medical University, Yokohama’s research hub for state-of-the-art medical science and services has acquired an ultra-high-resolution E-Class U-SPECT6/CT system for preclinical imaging. E-Class stands for “Economical Excellence” and is based on MILabs’ award-winning generation of broadband photon tomography. It is the only nuclear imaging system that can image mice with the same visual acuity as can be obtained from imaging humans with clinical scanners.

Kawasaki Medical University installs first MILabs E-Class U-SPECT6/CT in Japan
Prof. M. Inubushi and Dr. A. Mimura with their new U-SPECT6/CT system
(Commercial Innovation of the Year at the WMIC 2018 Congress)

Prof. Masayuki Inubushi, principal nuclear medicine investigator and a Japanese opinion leader in molecular imaging states:

If we expect to see structures in a mouse that we are used to see in human imaging, we will need to achieve comparable anatomical and functional resolution. Today, this resolution can only be achieved with a MILabs U-SPECT/CT system”.

Prof. Frederik Beekman, founder and CEO/CTO of MILabs comments:

We are grateful that our system can contribute to the pioneering translational research work of Prof. Inubushi. Among his past accomplishments are the first off simultaneous imaging of co-injected PET/SPECT complementary oncology tracers on a MILabs VECTor PET-SPECT-CT installed at the National Institute for Radiological Sciences in Japan”.

Source:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Non-invasive imaging test identifies patients needing heart procedures